Monday, October 22, 2012

Ultrasound: Collaborative Efforts to Develop Medical Ultrasound Practice Guidelines

American medical societies have collaborated on a guideline that comprises indications for an ultrasound examination for a focused reproductive endocrinology and infertility scan.

Sunday, October 21, 2012

Nuclear Medicine: The specificity and overall accuracy of F-18-FLT were considerably higher than F-18-FDG PET both during and after radiation therapy.

Determining the optimal treatment course and predicting outcomes may soon become simpler for head and neck sqaumous cell carcinomas (HNSCCs) patients with the use of a new investigational imaging agent.

Friday, October 19, 2012

Psoriasis: Investigation found a clear association between psoriasis and diabetes

An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.

Wednesday, October 17, 2012

Nuclear Medicine: New Radiation Treatment Significantly Increases Survival Rate

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D.,

Monday, October 15, 2012

Cosmetic Medicine: Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies

Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies, and could hold the key to maintaining a youthful appearance, according to scientists at Queen Mary, University of London.

Sunday, October 14, 2012

Drinking alcohol and smoking have to throw together

New research verifies previous studies by Dr. Timothy Durazzo and his colleagues, showing that smoking, while trying to quit drinking alcohol, impairs learning, memory, and other cognitive skills, hindering successful sobriety.

Wednesday, October 10, 2012

Value-based pricing is one potential solution to reduce the cost of drugs

A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.